Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, July 2001, p. 828-831, Vol. 8, No. 4
Laboratoire de Parasitologie-Mycologie,
Hôpital Henri Mondor-APHP and Université Paris XII,
Créteil,1 and Laboratoire de
Parasitologie-Mycologie, Hôpital
Bichat-APHP,2 Laboratoire de
Génétique Moléculaire, Faculté de
Pharmacie,3 and Laboratoire de
Parasitologie-Mycologie, Hôpital Saint-Louis-APHP and
Université Paris VI,4 Paris, France.
Received 20 November 2000/Returned for modification 9 January
2001/Accepted 19 March 2001
The parasitic loads of mouse livers experimentally infected with
Leishmania infantum were determined using a double
real-time quantitative PCR test targeted to the parasite DNA polymerase gene and to the mouse brain-derived neutrophic factor gene. The Leishmania DNA copy number was normalized to the number of
mouse gene copies in order to quantify the former independently of
liver weight. The correlation coefficient with the microtitration
method was 0.66. This PCR assay can be considered for experimental
pharmaceutical studies.
The leishmaniases are a group of
parasitic diseases of major and growing public health importance
(9). Standard therapies include pentavalent antimonials
and amphotericin B. These drugs cause secondary side effects, and
relapses are frequent. Therefore, other antileishmanial compounds
(11) or new formulations of existing ones
(14) are needed.
Mouse inoculation is the most used in vivo model of visceral
leishmaniasis for the evaluation of anti-Leishmania drugs
(5-7, 16). Assessment of parasitic burdens is usually
based on microscopic enumerations of amastigotes against host cell
nuclei on liver imprints (15). This type of assay is
time-consuming and subjective and is not reliable when the parasites
are not equally dispersed on the slides. More recently, culture
microtitrations have been developed (2, 17). These
techniques are more sensitive than the imprint method, but the assays
remain labor-intensive.
Since recurrences of leishmaniasis are associated with tissue loads of
residual, latent parasites after treatment, nonquantitative PCR tests
(3, 12, 13) are of little value in indicating a positive
or negative result. A recent approach for quantitation of DNA copy
number is based on the 5' nuclease activity of Taq polymerase for fragmentation of a dual-labeled fluorogenic
hybridization probe (8). A real-time quantitative TaqMan
PCR assay for measuring the copy numbers of Leishmania
infantum DNA in mouse liver was developed. A first possibility was
to use absolute quantitation. This requires the design of standards
known by independent means. Several critical points must be considered,
such as the reliability of the serial dilutions of the parasites, the
accuracy of pipetting, and the stability of the diluted standards. For
the present purpose, i.e., to quantify L. infantum in mouse
tissues, very precise weighing of liver biopsy specimens is also
necessary. Another possibility was to use relative quantification using
the Infections were conducted with 5-week-old BALB/c female mice and the
L. infantum MON1 (MHOM/FR92/LEM 2385) strain. Comparative studies of three techniques of counting the parasites were performed as
part of experimental studies of different drug regimens (antimonial pentavalent compounds versus liposomal amphotericin B). The Guiding Principles for Biomedical Research involving animals, published by the
Council for International Organizations of Medical Sciences, were
followed for all procedures. Mice were inoculated via the tail vein
with 107 L. infantum promastigotes in a 0.1-ml
volume. The livers of 33 control or treated mice were weighed and used
for each titration method.
Imprints from each liver were stained with Giemsa stain, and
amastigotes were enumerated against hepatic nuclei at a magnification of ×1,000. At least 100 microscopic fields were examined before an
imprint was reported as negative. Each positive result was expressed as
the number of amastigotes per 500 hepatic cell nuclei.
Culture microtitration was performed as previously described
(2). Briefly, a piece of liver was excised, weighed, and
homogenized. Serial fourfold dilutions ranging from 1 to 1/4
10 DNA was extracted from about 200 µg of liver biopsy specimens using
the High Pure DNA Extraction kit (Boehringer-Roche, Grenoble, France)
according to the manufacturer's recommendations. Ten microliters of
the 50 µl final elution was used for each PCR test, and each test was duplicated.
Two TaqMan systems were developed: the Leishmania TaqMan
system and the mouse TaqMan system. For the Leishmania
TaqMan system, the target DNA was the DNA polymerase of L. infantum (GenBank accession number AF009147), which is a
single-copy-number gene (4). The Leishmania
fluorogenic PCR system consisted of the amplification primers (forward
primer, 5'-TGTCGCTTGCAGACCAGATG-3'; reverse primer,
5'-GCATCGCAGGTGTGAGCAC-3') designed to amplify a 90-bp
fragment and the fluorogenic probe
(5'FAM-CAGCAACAACTTCGAGCCTGGCACC-3'TAMRA).
For the mouse TaqMan system, the target was the mouse brain-derived
neutrophic factor (BDNF) gene (GenBank accession number NM007540), a
single-copy-number housekeeping gene (10). The amplification primers (5'-TTGGATGCCGCAAACATGTC-3'
[forward] and 5'-CTGCCGCTGTGACCCACTC-3' [reverse])
were designed to amplify a 196-bp fragment. The fluorogenic probe
sequence was 5'FAM-TCACACACGCTCAGCTCCCCACGG-3'TAMRA.
Each amplification was performed in duplicate, in a 50-µl reaction
mixture using the components of the TaqMan PCR Core Reagents Kit
(Perkin-Elmer, les Ulis, France). The reaction mixture included: 1×
PCR TaqMan buffer; 3 mM MgCl2; 0.2 mM each dATP, dGTP, and dCTP; 0.4 mM dUTP; 20 pmol each of either L. infantum
primers or mouse BDNF primers (Perkin-Elmer, les Ulis, France); 0.5 U of uracyl-N-glycosylase (Perkin-Elmer, les Ulis, France),
1.25 U of AmpliTaq Gold (Perkin-Elmer, Roissy, France), and 10 µl of eluted sample. The samples were initially incubated for 2 min at 50°C
for optimum uracyl-N-glycosylase activity. This reaction was
followed by a 10-min incubation at 95°C to denature the DNA and to
activate the AmpliTaq Gold. The temperature cycling (50 cycles at
95°C for 15 s and 65°C for 1 min each) was performed in a 96-well
thermal cycler (Perkin-Elmer Applied Biosystems) in the same run for
both the L. infantum and the mouse gene amplifications. Each
amplification run contained several negative controls (buffer and
primers alone). Amplification data collected by the 7700 Sequence Detector and stored in the MacIntosh computer were then analyzed by use
of the Sequence Detection System software developed by Perkin-Elmer
Applied Biosystems. The threshold of detection was set at 10 times the
standard deviation above the mean baseline fluorescence calculated from
cycles 1 to 15. The fractional cycle number reflecting a positive PCR
result is called the cycle threshold (Ct). Both
PCR tests were performed on liver biopsy specimens by individuals
blinded to the results of the other titration techniques.
In initial experiments, we determined the dynamic range of the
real-time quantitative Leishmania TaqMan PCR test by making serial dilutions of L. infantum DNA in water, consisting of
the DNA equivalent from 5 × 106 to 5 cells. The
dilutions were subjected to analysis by the Leishmania TaqMan system (Fig. 1). The efficiency of
the amplification was close to 1. The intra-assay coefficient of
variation was below 1% for the high-concentration DNA and 1.6% for
the low-concentration DNA. Reproducibility was estimated by testing the
10-fold dilution 10 times in independent runs. The interassay
coefficient of variation was 6.4, 12.3, 13.8, and 36% for
103, 102, 10, and 1 parasite, respectively.
Similar results were obtained with the mouse BDNF TaqMan system (data
not shown).
1071-412X/01/$04.00+0 DOI: 10.1128/CDLI.8.4.828-831.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Real-Time PCR as a New Tool for Quantifying
Leishmania infantum in Liver in Infected Mice
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References

Ct method (1). In this
system, each sample tested is normalized on the basis of its mouse DNA
content, and the result is independent of the quantity of the DNA tested.
6 were distributed into 96-well microtitration plates
(Becton Dickinson). After 7 and 15 days at 27°C, the presence or
absence of mobile promastigotes was recorded in each well. The final
titer was the last dilution for which the well contained at least one parasite.

View larger version (75K):
[in a new window]
FIG. 1.
Amplification plots and a standard curve obtained with
the TaqMan Leishmania infantum PCR test. (A) Serial 10-fold
dilution of L. infantum DNA from 1 to 106 ng per
reaction (5 to 5 × 106 copies/reaction); the
amplification curves shift to the right as the input target quantity is
reduced, since reactions with fewer target molecules require more
amplification cycles to produce a detectable quantity of reporter
molecules than do reactions with more target molecules. (B) Standard
curve obtained by plotting the Ct against the input target quantity,
with the latter plotted on a common log scale. Ct represents the
fractional cycle number reflecting a positive PCR result differentiated
from the background noise.
The L. infantum DNA copies were quantitated using the

Ct method, which has been described in
detail elsewhere (1). Briefly, as the precise amount of
genomic DNA added to each reaction (based on optical density) is
difficult to assess, the L. infantum DNA copies were
normalized on the basis of their mouse gene copy content. The L. infantum DNA copies were also normalized to a calibrator, or 1×
sample, consisting of the sample among our tested series which
contained the fewest L. infantum DNA copies. Final results, expressed as fold differences in L. infantum gene copies
relative to the mouse gene copies and the calibrator, termed N
L. infantum, were calculated by the equation N L. infantum = 2
Ct = 2(
Ct sample
Ct calibrator), where
Ct of the sample and the calibrator is the
difference, in threshold cycle number, between the average of the
duplicate Ct value of the L. infantum
gene and the average of the duplicate Ct value
of the mouse gene. Although the absolute number of L. infantum gene copies in the calibrator is not known, this method allows one to ascertain that a sample with an N L. infantum
of x has x-fold more DNA copies than the
calibrator. Since we have initially checked that the efficiencies of
the L. infantum and mouse gene amplifications were
approximately equal and close to 1, and since, in testing 1/10-diluted
DNA liver samples, the relative quantification was similar, the
comparative 
Ct method was valid for our
PCR assays.
The range of enumeration of amastigotes against hepatic nuclei was 0 to
500 parasites per 500 hepatic cells. A high rate (11 of 33; 33%) of
negative results was observed. With the other two methods, negative
results were not observed in infected mice, and no organ with positive
imprints had a negative culture or a negative PCR result. The TaqMan
PCR assay results showed a normalized Leishmania gene copy
number between 1 and 1,968. The correlation between the TaqMan PCR
assay and the microtitration was calculated with the data expressed as
log10 units to assume a normal distribution of the results.
The correlation coefficient was 0.66 with a P of <0.01
(Fig. 2). Using the nonparametric
Spearman test, the correlation coefficient was 0.52 with a P
of <0.01.
|
To search for any unequal distribution of the parasites in the liver which could explain discrepancies between the techniques, five different liver biopsy specimens from two mice were tested using the TaqMan PCR test. The different liver biopsy specimens gave similar results, showing that the parasites were equally distributed in the liver.
The present work is the first development of TaqMan probes for L. infantum. Instead of quantifying the copy number with a standard curve, we chose a relative quantification according to the liver biopsy. In addition, we determined that liver infestation with Leishmania microorganisms is homogenous. Therefore, the biopsy can be performed anywhere in the liver, and very precise weighing is not necessary in using the double real-time PCR system.
Among the three quantitative techniques tested, the imprints had an
extremely high rate of negative results whereas the other techniques
gave positive results. Previous studies have shown that the liver
imprints were always negative for titers of
104 parasites
per g (2). Therefore, the imprint technique cannot be used
alone in a mouse model.
The correlation coefficient between TaqMan and microtitration was 0.66 (Fig. 2). One could have expected a better figure. However, the techniques could be complementary rather than redundant. Indeed, PCR is unable to distinguish between dead and live parasites. The DNA can come from the liver but also from circulating DNA originating in other cells or organs. The addition of a quantitative PCR test targeted at the mRNA of a housekeeping gene specific to Leishmania should discriminate between live and dead parasites. In contrast to the present TaqMan test, microtitration culture tests only the capability of live amastigotes to transform in vitro into mobile promastigotes. The microtitration technique gives functional information which cannot be directly linked to the number of parasites in the initial tissue. This reasoning may explain some of the aberrant points observed in comparing the microtitration culture method and the real-time quantitative tests. Keeping these limitations in mind, the double PCR TaqMan test developed in this study can give reliable results with a low workload compared with in vitro cultivation to assess the leishmanicidal effect of a given drug in mice.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by the "Agence Nationale de Recherche contre le SIDA" (grant TIB 9014).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Laboratoire de Parasitologie-Mycologie, Hôpital Henri Mondor, 51 avenue du Général DeLattre de Tassigny, 94010, Créteil, Cedex, France. Phone: 33 1 49 81 28 90. Fax: 33 1 49 81 36 01. E-mail: bretagne{at}univ-paris12.fr.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Bièche, I.,
B. Parfait,
V. Le Doussal,
M. Olivi,
M.-C. Rio,
R. Lidereau, and M. Vidaud.
2001.
Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy.
Cancer Res.
61:1652-1658 |
| 2. | Buffet, P. A., A. Sulahian, Y. J. Garin, N. Nassar, and F. Derouin. 1995. Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrob. Agents Chemother. 39:2167-2168[Abstract]. |
| 3. | Costa, J.-M., R. Durand, M. Deniau, D. Rivollet, M. Izri, R. Houin, M. Vidaud, and S. Bretagne. 1996. PCR enzyme-linked immunosorbent assay for diagnosis of leishmaniasis in human immunodeficiency virus-infected patients. J. Clin. Microbiol. 34:1831-1833[Abstract]. |
| 4. | Croan, D. G., D. A. Morrison, and J. T. Ellis. 1997. Evolution of the genus Leishmania revealed by comparison of DNA and RNA polymerase gene sequences. Mol. Biochem. Parasitol. 89:149-159[CrossRef][Medline]. |
| 5. | Durand, R., M. Paul, D. Rivollet, H. Fessi, R. Houin, A. Astier, and M. Deniau. 1997. Activity of pentamidine-loaded poly(D,L-lactide) nanoparticles against Leishmania infantum in a murine model. Parasite 4:331-336[Medline]. |
| 6. | Durand, R., M. Paul, D. Rivollet, R. Houin, A. Astier, and M. Deniau. 1997. Activity of pentamidine-loaded methacrylate nanoparticles against Leishmania infantum in a mouse model. Int. J. Parasitol. 27:1361-1367[CrossRef][Medline]. |
| 7. |
Gangneux, J. P.,
A. Sulahian,
Y. J. Garin, and F. Derouin.
1997.
Efficacy of aminosidine administered alone or in combination with meglumine antimoniate for the treatment of experimental visceral leishmaniasis caused by Leishmania infantum.
J. Antimicrob. Chemother.
40:287-289 |
| 8. |
Heid, C. A.,
J. Stevens,
K. J. Livak, and P. M. Williams.
1996.
Real-time quantitative PCR.
Genome Res.
6:986-994 |
| 9. | Herwaldt, B. L. 1999. Leishmaniasis. Lancet 354:1191-1199[CrossRef][Medline]. |
| 10. | Hofer, M., S. R. Pagliusi, A. Hohn, J. Leibrock, and Y. A. Barde. 1990. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J. 9:2459-2464[Medline]. |
| 11. |
Jha, T. K.,
S. Sundar,
C. P. Thakur,
P. Bachmann,
J. Karbwang,
C. Fischer,
A. Voss, and J. Berman.
1999.
Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis.
N. Engl. J. Med.
341:1795-1800 |
| 12. |
Lachaud, L.,
J. Dereure,
E. Chabbert,
J. Reynes,
J.-M. Mauboussin,
E. Oziol,
J.-P. Dedet, and P. Bastien.
2000.
Optimized PCR using patient blood samples for diagnosis and follow-up of visceral leishmaniasis, with special reference to AIDS patients.
J. Clin. Microbiol.
38:236-240 |
| 13. |
Osman, O. F.,
L. Oskam,
N. C. M. Kroon,
G. J. Schoone,
E. T. Khalil,
A. M. El-Hassan,
E. E. Zijlstra, and P. A. Kager.
1998.
Use of PCR for diagnosis of post-kala-azar dermal leishmaniasis.
J. Clin. Microbiol.
36:1621-1624 |
| 14. | Paul, M., R. Durand, H. Fessi, D. Rivollet, R. Houin, A. Astier, and M. Deniau. 1997. Activity of a new liposomal formulation of amphotericin B against two strains of Leishmania infantum in a murine model. Antimicrob. Agents Chemother. 41:1731-1734[Abstract]. |
| 15. | Stauber, L. A., E. M. Franchino, and J. Grun. 1958. An eight-day method for screening compounds against Leishmania donovani in golden hamster. J. Protozool. 5:269-273. |
| 16. | Sulahian, A., Y. J. Garin, F. Pratlong, J.-P. Dedet, and F. Derouin. 1997. Experimental pathogenicity of viscerotropic and dermotropic isolates of Leishmania infantum from immunocompromised and immunocompetent patients in a murine model. FEMS Immunol. Med. Microbiol. 17:131-138[CrossRef][Medline]. |
| 17. | Titus, R. G., M. Marchand, T. Boon, and J. A. Louis. 1985. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol. 7:545-555[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |